Breaking News
Get Actionable Insights with InvestingPro+: Start 7 Day FREE Trial Register here
Investing Pro 0
Ad-Free Version. Upgrade your Investing.com experience. Save up to 40% More details

Search Results for "MSD":

Results: 95

Quotes

MSD Morgan Stanley Emerging Markets Debt Closed Fund Stock - NYSE equities MSDA MSD Acquisition Corp Stock - NASDAQ equities MSDAU MSD Acquisition Corp Unit Stock - NASDAQ equities MSDc1 Silver Mini Futures Commodity - MCX commodity MSDc2 Silver Mini Futures Commodity - MCX commodity MSDc3 Silver Mini Futures Commodity - MCX commodity MSDIX Mainstay Mackay Strategic Bond Fund Class I Fund - US Funds fund MSDRX Wells Fargo Short Duration Government Bond Fund - Class R6 Fund - US Funds fund
Show all (8)

News

Morgan Stanley Emerging Markets Debt Fund declares $0.15 dividend
By Seeking Alpha

Morgan Stanley (NYSE:MS) Emerging Markets Debt Fund (NYSE:MSD) declares $0.15/share quarterly dividend, in line with previous.Forward yield 5.93%Payable July 14; for shareholders of record June 30;...

Morgan Stanley Emerging Markets Debt Fund declares $0.14 dividend
By Seeking Alpha

Morgan Stanley (NYSE:MS) Emerging Markets Debt Fund (NYSE:MSD) declares $0.14/share quarterly dividend, in line with previous.Forward yield 5.89%Payable April 13; for shareholders of record March...

Morgan Stanley Emerging Markets Debt Fund declares $0.14 dividend
By Seeking Alpha

Morgan Stanley (NYSE:MS) Emerging Markets Debt Fund (NYSE:MSD) declares $0.14/share quarterly dividend, -6.7% decrease from prior dividend of $0.15.Forward yield 5.48%Payable Oct. 13; for...

Show all (56)

Analysis

McKesson (MCK) Acquires Medical Specialties For $800 Million
By Zacks Investment Research

McKesson Corporation (MCK) recently completed its previously-announced acquisition of Medical Specialties Distributors (MSD) for a value of $800 million. The deal is part of a continuing effort by...

Immutep: Merck Collaboration Opens New Opportunities
By Edison

Immutep Ltd ADR (NASDAQ:Merk) & Co (MSD) for a Phase II study to evaluate eftilagimod alpha (IMP321) plus Keytruda in lung, head and neck and ovarian cancers. It is positive to see Immutep...

Immutep: A Second Big Pharma Collaboration For Efti
By Edison

Immutep Ltd ADR (NASDAQ:IMMP) has entered into a clinical trial collaboration and supply agreement with Merck/Pfizer to investigate the combination of its APC activator eftilagimod alpha (efti) with...

Show all (31)
Results: 8

Refine Results

Instrument Type

Region

 

Country

Exchange

Sector

 

Industry

 
Results: 56

Refine Results

Date

Date
 

Category

Provider

 

News

{{title}}
By {{provider}}

{{content}}

Please try another search

Results: 31

Refine Results

Date

Date
 

Category

Author

Analysis

{{title}}
By {{provider}}

{{content}}

Results: 0

Refine Results

Country

Importance

Economic Events

Results: 0

Tools & Sections

Results: 0

Authors

Continue with Google
or
Sign up with Email